Trending Now
Artelo Biosciences Inc. (NASDAQ:ARTL) Announces its Q4 and FY2020 Financial Results...
Artelo Biosciences Inc. (NASDAQ:ARTL) has announced its financial and operating results for Q4 and fiscal 2020 year ended August 31, 2020, and offered a...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Evofem Biosciences Inc. (NASDAQ: EVFM) Enters Collaboration Agreement With Orion Biotechnology...
Evofem Biosciences Inc. (NASDAQ: EVFM) has signed a partnership agreement with Orion Biotechnology Canada Ltd to assess the stability and compatibility of...
MAKE IT MODERN
LATEST REVIEWS
Grid Battery Metals Inc (EVKRF) Update to Shareholders: Focusing on the...
Grid Battery Metals Inc., often referred to as "Grid Battery" or the "Company" (represented on the stock market as TSXV:CELL, OTCQB:EVKRF, and...
MAKE IT MODERN
PERFORMANCE TRAINING
Annovis Bio (NASDAQ: ANVS) Tanks On Disappointing Posiphen Study Results
Annovis Bio (NASDAQ: ANVS) stock tanked on Thursday after its touted Alzheimer's disease drug flopped and failed to show a significant difference in a...
Kintara Therapeutics Inc. (NASDAQ: KTRA) Announce Multi-Year Grant for to Dr. Anna Golebiewska’s DBM...
Kintara Therapeutics Inc. (NASDAQ: KTRA) has announced a multi-year research grant from Luxembourg National Research Fund (FNR) and Cancer Foundation Luxembourg to Dr. Anna...
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Submits sNDA For Approval Of NUPLAZID (pimavanserin) In Dementia-Related Psychosis
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) has announced the submission of a supplemental new drug application (sNDA) seeking approval from the FDA for its NUPLAZID (pimavanserin)...
Aldeyra Therapeutics Inc (NASDAQ:ALDX) Enters A Pact With FDA To Use RASP To Treat...
Aldeyra Therapeutics Inc (NASDAQ:ALDX) advances several clinical-stage programs that focus on developing ADX-629 and reproxalap. The company held discussions with the FDA in June...
CDE China Grants IND Approval For Vicineum Of Sesen Bio Inc (NASDAQ:SESN)
Sesen Bio Inc (NASDAQ:SESN) is pleased to announce the receipt of IND approval for its innovative drug – Vicineum, from CDE (Center...
MAKE IT MODERN
